4-amino-1,8-naphthalimide has been researched along with Neuralgia in 2 studies
4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komirishetty, P | 1 |
| Areti, A | 1 |
| Gogoi, R | 1 |
| Sistla, R | 1 |
| Kumar, A | 2 |
| Sharma, SS | 1 |
| Arora, M | 1 |
| Kaundal, RK | 1 |
2 other studies available for 4-amino-1,8-naphthalimide and Neuralgia
| Article | Year |
|---|---|
Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy.
Topics: 1-Naphthylamine; Adenosine Triphosphate; Animals; Antioxidants; Encephalitis; Hyperalgesia; Male; Mi | 2017 |
Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Topics: 1-Naphthylamine; Animals; Antioxidants; Diabetic Neuropathies; Male; Malondialdehyde; NAD; Naphthali | 2009 |